Načítá se...

Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis

High mobility group box 1 (HMGB1) is an established inflammatory mediator when released from cells. Recent studies have implicated extracellular HMGB1 in the pathogenesis of various autoimmune diseases. The objective of this study was to determine whether HMGB1 could be a therapeutic target for expe...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Uzawa, A, Mori, M, Taniguchi, J, Masuda, S, Muto, M, Kuwabara, S
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3719929/
https://ncbi.nlm.nih.gov/pubmed/23480183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12036
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!